PHASE I/IB STUDY OF LONAFARNIB AND TEMOZOLOMIDE IN PATIENTS WITH RECURRENT OR TEMOZOLOMIDE REFRACTORY GLIOBLASTOMA

被引：0
|
作者：
Yust-Katz, Shlomit [1 ]
Liu, Vivian [1 ]
Sanghee, Kang [1 ]
Groves, Moriss [1 ]
Puduvalli, Vinay [1 ]
Levin, Victor [1 ]
Conrad, Charles [1 ]
Colman, Howard [2 ]
Hsu, Sigmund [1 ]
Yung, Alfred W. [1 ]
Gilbert, Mark R. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Utah, Salt Lake City, UT USA
来源：
NEURO-ONCOLOGY | 2012年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：68 / 68
页数：1
相关论文
共 50 条
  • [1] Phase 1/1b study of lonafarnib and temozolomide in patients with recurrent or temozolomide refractory glioblastoma
    Yust-Katz, Shlomit
    Liu, Diane
    Yuan, Ying
    Liu, Vivien
    Kang, Sanghee
    Groves, Morris
    Puduvalli, Vinay
    Levin, Victor
    Conrad, Charles
    Colman, Howard
    Hsu, Sigmonid
    Yung, W. K. Alfred
    Gilbert, Mark R.
    CANCER, 2013, 119 (15) : 2747 - 2753
  • [2] METRONOMIC TEMOZOLOMIDE TREATMENT IN PATIENTS WITH RECURRENT TEMOZOLOMIDE-REFRACTORY GLIOBLASTOMA
    Kim, Jong-Hyun
    Kong, Doo-Sik
    Lee, Jung-Il
    Park, Kwan
    Nam, Do-Hyun
    NEURO-ONCOLOGY, 2009, 11 (02) : 228 - 228
  • [3] A pilot study of metronomic temozolomide treatment in patients with recurrent temozolomide-refractory glioblastoma
    Kong, Doo-Sik
    Lee, Jung-Il
    Kim, Won Seog
    Son, Myung Jin
    Lim, Do Hoon
    Kim, Sung Tae
    Park, Kwan
    Kim, Jong Hyun
    Eoh, Whan
    Nam, Do-Hyun
    ONCOLOGY REPORTS, 2006, 16 (05) : 1117 - 1121
  • [4] A phase I study of irinotecan in combination with metronomic temozolomide in patients with recurrent glioblastoma
    Reynes, Gaspar
    Balana, Carmen
    Gallego, Oscar
    Iglesias, Luis
    Perez, Pedro
    Garcia, Jose L.
    ANTI-CANCER DRUGS, 2014, 25 (06) : 717 - 722
  • [5] Phase 2 study of temozolomide and Caelyx in patients with recurrent glioblastoma multiforme
    Chua, SL
    Rosenthal, MA
    Wong, SS
    Ashley, DM
    Woods, AM
    Dowling, A
    Cher, LM
    NEURO-ONCOLOGY, 2004, 6 (01) : 38 - 43
  • [6] Vorinostat, temozolomide, and bevacizumab for patients with recurrent glioblastoma: A phase I/II trial
    Peters, Katherine B.
    Vredenburgh, James J.
    Desjardins, Annick
    Friedman, Henry S.
    Herndon, James Emmett
    Coan, April D.
    McSherry, Frances
    Lipp, Eric S.
    Brickhouse, Alise
    Massey, Woody C.
    Reardon, David A.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [7] A phase 2 study of temozolomide (TMZ) and the farnesyltransferase inhibitor (FTI) lonafarnib (Sarazar™, SCH66336) in recurrent glioblastoma
    Gilbert, M
    Hess, K
    Liu, V
    Groves, M
    Puduvalli, V
    Levin, V
    Conrad, C
    Colman, H
    Hsu, S
    Sugrue, MM
    Yung, WKA
    NEURO-ONCOLOGY, 2005, 7 (03) : 401 - 401
  • [8] Phase Ib study of cediranib in combination with daily temozolomide and radiation in patients with newly diagnosed glioblastoma
    Chi, A. S.
    Gerstner, E. R.
    Eichler, A. F.
    Chea, H. K.
    Drappatz, J.
    Wen, P. Y.
    Ivy, S. P.
    Loeffler, J. S.
    Sorensen, A. G.
    Jain, R. K.
    Batchelor, T. T.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [9] A multicenter phase II study of temozolomide plus disulfiram and copper for recurrent temozolomide-resistant glioblastoma
    Huang, Jiayi
    Chaudhary, Rekha
    Cohen, Adam L.
    Fink, Karen
    Goldlust, Samuel
    Boockvar, John
    Chinnaiyan, Prakash
    Wan, Leping
    Marcus, Stephen
    Campian, Jian L.
    JOURNAL OF NEURO-ONCOLOGY, 2019, 142 (03) : 537 - 544
  • [10] A phase I study of nelfinavir concurrent with temozolomide and radiotherapy in patients with glioblastoma multiforme
    Alonso-Basanta, Michelle
    Fang, Penny
    Maity, Amit
    Hahn, Stephen M.
    Lustig, Robert A.
    Dorsey, Jay F.
    JOURNAL OF NEURO-ONCOLOGY, 2014, 116 (02) : 365 - 372
12345